In 1999, Elgun found a decline of adenosine deaminase (ADA) activity in the plasma of patients with major depression, and it had a negative correlation with the severity of depression, which indirectly suggested that adenosine may be involved in the pathological changes of major depression. This evidence concerns the gene ADA and depressive symptom measurement.